Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human β3-adrenergic receptor agonists with high cell permeability
- 10 November 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 13 (3) , 855-868
- https://doi.org/10.1016/j.bmc.2004.10.032
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human β3-adrenergic receptor agonists with high cell permeabilityBioorganic & Medicinal Chemistry, 2004
- BMS-201620: a selective beta 3 agonistBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and Evaluation of Potent and Selective β3 Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid IsosteresJournal of Medicinal Chemistry, 2001
- Beta3 -Adrenoceptor Agonists as Anti-diabetic and Anti-obesity Drugs in HumansCurrent Pharmaceutical Design, 2001
- Property-Based Design: Optimization of Drug Absorption and PharmacokineticsJournal of Medicinal Chemistry, 2001
- L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailabilityBioorganic & Medicinal Chemistry Letters, 1999
- Functional and molecular biological evidence for a possible β3‐adrenoceptor in the human detrusor muscleBritish Journal of Pharmacology, 1999
- Possible β3‐adrenoceptor‐mediated relaxation of the human detrusorActa Physiologica Scandinavica, 1998
- β3-adrenergic agonists: potential therapeutics for obesityExpert Opinion on Investigational Drugs, 1997
- Carboxyl-promoted enhancement of selectivity for the β3 adrenergic receptor. Negative charge of the sulfonic acid BMS-187413 introduces-β3 binding selectivityBioorganic & Medicinal Chemistry Letters, 1997